Millennium Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-190,625
| Closed | -$9.12M | – | 6465 |
|
|
2025
Q3 | $9.12M | Sell |
190,625
-53,251
| -22% | -$1.48M | ﹤0.01% | 2472 |
|
|
2025
Q2 | $3.9M | Sell |
243,876
-24,862
| -9% | -$403K | ﹤0.01% | 3241 |
|
|
2025
Q1 | $4.09M | Sell |
268,738
-95,920
| -26% | -$1.54M | ﹤0.01% | 3061 |
|
|
2024
Q4 | $7.4M | Sell |
364,658
-144,757
| -28% | -$3.65M | ﹤0.01% | 2453 |
|
|
2024
Q3 | $13.1M | Buy |
+509,415
| New | +$8.5M | 0.01% | 1951 |
|
|
2024
Q2 | – | Sell |
-137,587
| Closed | -$3.15M | – | 6544 |
|
|
2024
Q1 | $3.15M | Buy |
137,587
+117,201
| +575% | +$4.13M | ﹤0.01% | 3321 |
|
|
2023
Q4 | $534K | Buy |
20,386
+4,621
| +29% | +$92.5K | ﹤0.01% | 4603 |
|
|
2023
Q3 | $443K | Sell |
15,765
-16,443
| -51% | -$481K | ﹤0.01% | 4736 |
|
|
2023
Q2 | $979K | Buy |
+32,208
| New | +$822K | ﹤0.01% | 4065 |
|
|
2022
Q4 | – | Sell |
-5,323
| Closed | -$140K | – | 7061 |
|
|
2022
Q3 | $140K | Buy |
+5,323
| New | +$194K | ﹤0.01% | 5837 |
|
Millennium Management's TRML Position: Q4 2025 in Review
Millennium Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 190,625 shares — an estimated $9.12M sold.
Millennium Management first reported a position in TRML in Q3 2022 and held it in 10 quarters. The position peaked at $13.1M in Q3 2024. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.
- Millennium Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
- Millennium Management sold 190,625 Tourmaline Bio shares in Q4 2025, an estimated $9.12M.
- Millennium Management first reported a position in Tourmaline Bio in Q3 2022 and held it in 10 quarters.
- Millennium Management's Tourmaline Bio position peaked at $13.1M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.